Although the correlation between tumor mutational burden (TMB) (DNA variants per Mb) and increased survival was not statistically significant, we observed a positive trend and the overall number of DNA variants correlated positively with increased survival in our heterogenous cohort (Supplementary Fig. 5e ).
← all excerpts
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
1
—
—